THC shareholder plans Rule 144 sale of 2,178 common shares

THC reports that a holder of its common stock plans to sell 2,178 shares under Rule 144.

Rhea-AI Filing Summary

THC reports that a holder of its common stock plans to sell 2,178 shares under Rule 144. The sale is expected to be executed through Fidelity Brokerage Services on the NYSE around 12/15/2025, with an aggregate market value of 430,097.46 based on the figures provided.

The shares were acquired on 05/07/2024 through restricted stock vesting from the issuer as compensation. The same table lists 87,885,000 common shares outstanding. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about the issuer and, if using a Rule 10b5-1 trading plan, that this representation applied when the plan or trading instructions were adopted.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many THC shares are proposed to be sold under this Rule 144 notice?

The notice states that 2,178 THC common shares are planned to be sold under Rule 144.

On which exchange and through which broker will the THC shares be sold?

The planned sale is through Fidelity Brokerage Services LLC on the NYSE.

What is the aggregate market value of the THC shares to be sold?

The filing lists an aggregate market value of 430,097.46 for the 2,178 common shares.

When were the THC shares being sold under Rule 144 originally acquired?

The shares were acquired on 05/07/2024 through restricted stock vesting from the issuer as compensation.

How many THC common shares are shown as outstanding in this notice?

The table in the notice lists 87,885,000 common shares as outstanding.

What representation does the seller make about undisclosed information on THC?

By signing, the seller represents they do not know any material adverse information about THC’s current or prospective operations that has not been publicly disclosed, and makes this representation as of any Rule 10b5-1 plan adoption or instruction date if such a plan is used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/15/2025 - 03:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001787802
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TENET HEALTHCARE CORP
SEC File Number	001-07293
Address of Issuer	14201 DALLAS PARKWAY DALLAS TEXAS 75254
Phone	469-893-2200
Name of Person for Whose Account the Securities are To Be Sold	West Nadja
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2178	430097.46	87885000	12/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/07/2024	Restricted Stock Vesting	Issuer			2178	05/07/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	12/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Nadja West
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)